10.5281/zenodo.1238932
https://zenodo.org/records/1238932
oai:zenodo.org:1238932
Harding, Rachel
Rachel
Harding
0000-0002-1134-391X
S
Ravichandran, Mani
Mani
Ravichandran
Structural Genomics Consortium, University of Toronto
Arrowsmith, Cheryl
Cheryl
Arrowsmith
Structural Genomics Consortium, University of Toronto
Edwards, Aled
Aled
Edwards
Structural Genomics Consortium, University of Toronto
Huntingtin Exon 1 Q16 and Q46 pET32a thioredoxin tagged expression and purification 2018/04/02
Zenodo
2018
Huntingtin
HD
Huntington's disease
Exon 1
Protein purification
2018-04-02
10.5281/zenodo.1238931
https://zenodo.org/communities/labscribbles
https://zenodo.org/communities/sgc-opennotebook
https://zenodo.org/communities/openlabnotebooks
Creative Commons Attribution 4.0 International
Huntingtin structure-function open lab notebook project. Huntingtin Exon 1 Q16 and Q46 pET32a thioredoxin tagged, attempted expression and purification 2018/04/02
The SGC is a registered charity (number 1097737) that receives funds from AbbVie, Bayer Pharma AG, Boehringer Ingelheim, Canada Foundation for Innovation, Eshelman Institute for Innovation, Genome Canada through Ontario Genomics Institute [OGI-055], Innovative Medicines Initiative (EU/EFPIA) [ULTRA-DD grant no. 115766], Janssen, Merck KGaA, Darmstadt, Germany, MSD, Novartis Pharma AG, Ontario Ministry of Research, Innovation and Science (MRIS), Pfizer, São Paulo Research Foundation-FAPESP, Takeda, and Wellcome.